Aller au contenu principal
2026 article

1056 Endothelial Cell-Specific MTORC1 Activation Promotes Cerebral Aneurysm Formation

0Citations signalées, ce qui n’est pas une note de qualité
0Institutions déclarées
0Pays d’affiliation déclarés

Le résumé fourni par la source

INTRODUCTION: Cerebral aneurysms affect up to 6–10 million individuals in the United States. Endothelial cell (EC) dysfunction is a key contributor to aneurysm formation and rupture. The mTORC1 pathway regulates EC proliferation, metabolism, and inflammatory signaling. Although inhibition of mTORC1 reduces aneurysm burden, the effect of EC-specific mTORC1 activation on aneurysm pathophysiology remains unclear. METHODS: We used a validated elastase-induced mouse model of cerebral aneurysm combined with systemic hypertension. Conditional EC-specific deletion of TSC1, a negative regulator of mTORC1, was achieved using tamoxifen-inducible VE-cadherin Cre-loxP technology. Four groups were studied: sham, wild-type aneurysm, TSC1 knockout with tamoxifen (mTORC1 activation), and TSC1 knockout without tamoxifen. Mice were sacrificed 28 days post-induction. Brains were harvested and perfused with blue gelatin for aneurysm visualization. Aneurysm formation and rupture were recorded. Histology, immunohistochemistry, and RT-PCR assessed EC dysfunction, apoptosis, inflammation, and remodeling markers. RESULTS: Rapamycin significantly reduced aneurysm progression (6/25 vs. 15/25; p = 0.012) without affecting formation rate (p = 0.73). Elastase-induced aneurysms showed vessel wall thinning, elastic lamina disruption, and EC death. Preliminary data from EC-specific mTORC1-activated mice suggest increased aneurysm rupture, upregulation of pro-inflammatory genes (e.g., IL-1β, VCAM-1, MMP9), decreased EC marker expression, increased apoptosis, and reduced proliferation. CONCLUSIONS: Endothelial mTORC1 activation plays a direct role in vascular dysfunction, inflammation, and aneurysm progression. These findings highlight a mechanistic role for EC signaling in aneurysm pathogenesis and suggest mTORC1 as a potential therapeutic target. Further investigation may support the development of pharmacologic strategies to prevent aneurysm rupture.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
1056 Endothelial Cell-Specific MTORC1 Activation Promotes Cerebral Aneurysm Formation
Date Crossref
01/04/2026
Éditeur
Ovid Technologies (Wolters Kluwer Health)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les sujets associés

Cerebrovascular and genetic disordersBarrier Structure and Function StudiesIntracranial Aneurysms: Treatment and Complications

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.